Why I’ve Bought Chemring Group Plc

Chemring Group plc (LON:CHG) is the cheapest company in the defence sector.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As stock markets globally have risen, contrarians seeking out cheap shares, myself included, have found fewer bargains. However, defence company Chemring (LSE: CHG) recently caught my attention.

This company’s share price has been what investors term a ‘falling knife’. Since its peak in 2010 the share price has been tumbling lower and lower after a succession of disappointing results. Last month’s numbers sent Chemring’s shares even lower. In simple terms, the share price is now less than a third of its all-time high.

No company grows forever

At some point, the growth rate of a company that has been booming suddenly slows. When this happens, the market reassesses its view of this company, and often the share price crashes as the company is re-rated. Examples in the recent past of this include car insurance company Admiral and satellite company Inmarsat.

This is basically the market adjusting to reality, as no company grows forever. That’s what you always have to be wary of in-growth companies — after all, no tree grows to the sky. At some point, the growth ends.

But when the share price crashes, often there is too much pessimism. The value of the company crashes further and faster than anyone expects. The fear is that the share price will eventually fall to zero. But if the company is fundamentally strong, and its earnings are steady, the share price will actually recover.

So those who buy at the time of the crash can actually make a tidy profit. This is, as John Templeton called it, ‘the time of maximum pessimism’. How can you judge this? Well, it’s not easy, but I typically look for a discrepancy between the negative sentiment and the predicted performance of the company.

A growth company which has turned into an income investment

This is what I now see for Chemring. It is now rated on a P/E ratio of just 10, which is predicted to be steady in future years — this looks cheap to me, plus there is a juicy dividend yield. Yet the share price has been crashing through the floor.

This is a defence company, and admittedly defence is not a growth sector. But take BAE Systems: last year this was also an unloved, unwanted defence stock. But many canny investors, including Neil Woodford, invested in the company. It turned out to be an astute buy, rocketing over the past year and substantially out-performing the wider market.

This is the art of contrarian investing — it might sound easy, but it is actually really difficult. That’s why most investors can’t beat the market. That’s why the world has only one Warren Buffett.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Prabhat owns shares in Chemring.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »

Google office headquarters
Investing Articles

A dividend announcement sends the Alphabet share price soaring. Here’s what investors need to know

As the Alphabet share price surges on the announcement of a dividend, Stephen Wright outlines what investors should really be…

Read more »